Showing results (251-260 of 538) with videos related to

Sort By:
Pageof 54
Annals of the Rheumatic Diseases|September 5, 2006
Tolerance and efficacy of rituximab and changes in serum B cell biomarkers in patients with systemic complications of primary Sjögren's syndromeRaphaèle Seror, Christelle Sordet, Loic Guillevin, et al.
Joint Bone Spine|December 9, 2008
Exposition to anti-TNF drugs during pregnancy: outcome of 15 cases and review of the literatureJean-Marie Berthelot, Michel De Bandt, Philippe Goupille, et al.
RMD Open|June 28, 2019
Long-term safety of certolizumab pegol in rheumatoid arthritis, axial spondyloarthritis, psoriatic arthritis, psoriasis and Crohn's disease: a pooled analysis of 11 317 patients across clinical trialsJeffrey R Curtis, Xavier Mariette, Cécile Gaujoux-Viala, et al.
Arthritis Research & Therapy|March 17, 2024
Sensitive B-cell receptor repertoire analysis shows repopulation correlates with clinical response to rituximab in rheumatoid arthritisSabrina Pollastro, Anne Musters, Giulia Balzaretti, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|April 8, 2024
Drug hypersensitivity reactions: review of the state of the science for prediction and diagnosisMarc Pallardy, Rami Bechara, Jessica Whritenour, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 24, 2021
Tumor Necrosis Factor Inhibitors and the Risk of Cancer among Older Americans with Rheumatoid ArthritisMonica E D'Arcy, Daniel C Beachler, Ruth M Pfeiffer, et al.
BMC Medical Research Methodology|March 21, 2020
Assessing the effect of genetic markers on drug immunogenicity from a mechanistic model-based approachJulianne Duhazé, Miguel Caubet, Signe Hässler, et al.
Rheumatology (Oxford, England)|March 4, 2023
Identification of new candidate drugs for primary Sjögren's syndrome using a drug repurposing transcriptomic approachRenaud Felten, Tao Ye, Cedric Schleiss, et al.
Rheumatology (Oxford, England)|September 11, 2009
Evaluation of two strategies (initial methotrexate monotherapy vs its combination with adalimumab) in management of early active rheumatoid arthritis: data from the GUEPARD trialMartin Soubrier, Xavier Puéchal, Jean Sibilia, et al.
Arthritis and Rheumatism|December 4, 2012
Down-regulation of interferon signature in systemic lupus erythematosus patients by active immunization with interferon α-kinoidBernard R Lauwerys, Eric Hachulla, François Spertini, et al.
Pageof 54